TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+20.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.64B
AUM Growth
+$2.64B
(+15%)
Cap. Flow
-$3.06M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
38.92%
Holding
218
New
26
Increased
62
Reduced
55
Closed
4
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$15.6M |
| 2 |
Johnson & Johnson
JNJ
|
$14.4M |
| 3 |
Cigna
CI
|
$13.4M |
| 4 |
Abbott
ABT
|
$13M |
| 5 |
Milestone Pharmaceuticals
MIST
|
$11.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$146M |
| 2 |
UnitedHealth
UNH
|
$26M |
| 3 |
Humana
HUM
|
$10.7M |
| 4 |
Intuitive Surgical
ISRG
|
$9.93M |
| 5 |
Zoetis
ZTS
|
$7.76M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Real Estate | 3.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Idexx Laboratories
IDXX
$51.8B
| $11.4M | 0.43% | 43,614 -6,162 | -12% | -$1.61M |
|
52
Ventas
VTR
$30.9B
| $11.1M | 0.42% | 191,388 +50,269 | +36% | +$2.9M |
|
|
HZNP
53
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11M | 0.42% | 304,664 +89,934 | +42% | +$3.26M |
|
54
Bio-Techne
TECH
$8.5B
| $11M | 0.42% | 50,091 +19,554 | +64% | +$4.29M |
|
55
Baxter International
BAX
$12.7B
| $10.9M | 0.41% | 129,983 -34,975 | -21% | -$2.92M |
|
56
Agios Pharmaceuticals
AGIO
$2.19B
| $10.3M | 0.39% | 216,408 +74,191 | +52% | +$3.54M |
|
|
IMMU
57
DELISTED
Immunomedics Inc
IMMU
| $10.3M | 0.39% | 487,103 | – | – |
|
|
MDCO
58
DELISTED
Medicines Co
MDCO
| $10.3M | 0.39% | 120,670 -15,005 | -11% | -$1.27M |
|
59
Sabra Healthcare REIT
SBRA
$4.58B
| $9.95M | 0.38% | 466,247 | – | – |
|
60
Cencora
COR
$56.5B
| $9.84M | 0.37% | 115,723 -58,615 | -34% | -$4.98M |
|
61
Ascendis Pharma
ASND
$11.8B
| $9.65M | 0.36% | 69,332 -7,835 | -10% | -$1.09M |
|
62
Zimmer Biomet
ZBH
$21B
| $9.53M | 0.36% | 63,671 -13,900 | -18% | -$2.08M |
|
63
Centene
CNC
$14.3B
| $9.4M | 0.36% | +149,526 | New | +$9.4M |
|
64
Sanofi
SNY
$121B
| $9.37M | 0.35% | 186,640 +100,699 | +117% | +$5.05M |
|
|
BPMC
65
DELISTED
Blueprint Medicines
BPMC
| $9.37M | 0.35% | 116,925 +16,009 | +16% | +$1.28M |
|
66
Acadia Pharmaceuticals
ACAD
$4.38B
| $9.34M | 0.35% | 218,283 +58,136 | +36% | +$2.49M |
|
67
McKesson
MCK
$85.4B
| $9.31M | 0.35% | 67,325 -39,941 | -37% | -$5.52M |
|
|
MRTX
68
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.13M | 0.35% | 70,873 -8,814 | -11% | -$1.14M |
|
69
Exelixis
EXEL
$10.1B
| $9.08M | 0.34% | 515,125 +183,374 | +55% | +$3.23M |
|
70
NovoCure
NVCR
$1.38B
| $9.05M | 0.34% | 107,438 +6,506 | +6% | +$548K |
|
|
AMRN
71
Amarin Corp
AMRN
$311M
| $8.75M | 0.33% | 408,120 +119,563 | +41% | +$2.56M |
|
|
EPZM
72
DELISTED
Epizyme, Inc
EPZM
| $8.69M | 0.33% | 353,102 -46,502 | -12% | -$1.14M |
|
|
DOC
73
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $8.65M | 0.33% | 456,756 +152,848 | +50% | +$2.89M |
|
|
BLUE
74
DELISTED
bluebird bio
BLUE
| $8.4M | 0.32% | 95,687 -44,599 | -32% | -$3.91M |
|
75
FibroGen
FGEN
$47.8M
| $8.33M | 0.32% | 194,270 -38,872 | -17% | -$1.67M |
|